You are here

Vivitrol

Alkermes fends off generic versions of Vivitrol until 2027

Clinical Trials Arena

Thu, 08/31/23 - 06:07 pm

Teva Pharmaceutical

FDA slaps down Alkermes for misleading Vivitrol ads — don't forget vulnerability to opioid overdose

Endpoints

Wed, 12/11/19 - 10:24 pm

Alkermes in pay-for-performance deal

BioCentury

Sat, 09/1/18 - 04:10 pm

opioid addiction

pay-for-performance

Trump opioid plan writes in favoritism to single company’s addiction medication

Stat

Mon, 03/26/18 - 10:08 am

opioid addiction

Alkermes touts equal efficacy of monthly Vivitrol against daily Suboxone

Endpoints

Wed, 11/15/17 - 08:58 pm

Alkermes balks at U.S. senator’s probe into 'aggressive' Vivitrol lobbying and marketing

Fierce Pharma

Tue, 11/7/17 - 09:32 pm

Once-a-month shot for opioid addiction works as well as daily medication, study finds

Stat

Thu, 10/19/17 - 09:23 am

opioid addiction

Alkermes’ Vivitrol marketing and lobbying put it under gun; pharma says not fair

Fierce Pharma

Fri, 07/14/17 - 08:16 am

CNBC interviews Alkermes CEO about antidepressant comeback

Thu, 10/27/16 - 04:08 pm

Alkermes' Drug Approval On Tap

Investors.com

Tue, 10/19/10 - 10:28 pm

Don't Get Addicted to Alkermes' Low Revenue

Motley Fool

Wed, 10/13/10 - 04:08 pm

FDA panel urges wider use for Alkermes drug

Reuters

Fri, 09/17/10 - 11:55 am

advisory panels

Good News for Alkermes' Pipeline

Yahoo/Zacks.com

Wed, 11/18/09 - 10:16 am